BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Business

  Xenomics Inc. Names Renowned Research Oncologist And Biotechnology Executive Dr. David Sidransky To Board Of Directors

  September 5, 2006

   · 

  3 min read
• Drug Development

  Talecris Biotherapeutics Release: Extensive Post-License Data Reaffirm Clinical Safety Profile of Prolastin(R); Data Set from 18 Years of Experience Represents Largest and Longest among Alpha-1 Antitrypsin Augmentation Therapies

  September 5, 2006

   · 

  1 min read
• Business

  GammaCan International, Inc. Announces Appointment Of Richard Spritz, M.D. To Scientific Advisory Board; Leading Geneticist And Pediatric Specialist To Assist Company In Researching And Achieving Milestones In Its Efforts To Bring VitiGam To The Clinic

  September 5, 2006

   · 

  1 min read
• Health Discovery Corporation Secures $1,000,000 In New Financing; New Funding Significantly Strengthens HDC’s Financial Position

  September 5, 2006

   · 

  1 min read
• Cordis Corporation Release: Two-Year Data Suggest Different Rates Of Blood Clots And Heart Attacks Between The CYPHER(R) Sirolimus-Eluting Coronary Stent And The Taxus Stent

  September 5, 2006

   · 

  3 min read
• Biotech Bay

  Conor Medsystems, Inc. Announces Two-Year Follow-Up Data From EuroSTAR Pivotal Study

  September 5, 2006

   · 

  4 min read
• Business

  Sterigenics International, Inc. Announces Major Expansion In Shanghai

  September 5, 2006

   · 

  2 min read
• Deals

  Arcadia Resources Closes Durable Medical Equipment Acquisition In North Carolina; Adds $3 Million In Sales

  September 5, 2006

   · 

  3 min read
• Drug Development

  GlaxoSmithKline And Adolor Corporation Report Top-Line Results From Phase 3 Studies Of Alvimopan (Entereg/Entrareg(R)); Report Mixed Results

  September 5, 2006

   · 

  12 min read
• Policy

  US FDA Staff Question Benefits Of Genta Incorporated’s Genasense; Shares Halted Pending Outcome Of FDA Panel Hearing

  September 5, 2006

   · 

  1 min read